Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
dulaglutide (GLP-1Fc) (LY2189265)
print preview
bookmark
share with colleague
General Information
Company
Eli Lilly and Co.
Description
Long-acting glucagon-like peptide-1 (GLP-1) receptor agonist
Molecular Target
Glucagon-like peptide-1 (GLP-1)
Mechanism of Action
Glucagon-like peptide-1 (GLP-1) receptor agonist
Latest Stage of Development
Phase III
Indication
Diabetes
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy